J 2023

Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic

KUBÍČEK, Luboš, Radek VITASEK, David SCHWARZ, Robert STAFFA, Petr STRAKOS et. al.

Základní údaje

Originální název

Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic

Autoři

KUBÍČEK, Luboš (203 Česká republika, garant, domácí), Radek VITASEK (203 Česká republika), David SCHWARZ (203 Česká republika), Robert STAFFA (203 Česká republika, domácí), Petr STRAKOS (203 Česká republika) a Stanislav POLZER (203 Česká republika)

Vydání

Diagnostics, Basel, MDPI, 2023, 2075-4418

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30212 Surgery

Stát vydavatele

Švédsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.600 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130353

Organizační jednotka

Lékařská fakulta

UT WoS

000909283300001

Klíčová slova anglicky

abdominal aortic aneurysm; biomechanics; rupture risk; predictability; COVID-19

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 19. 2. 2024 15:23, Mgr. Tereza Miškechová

Anotace

V originále

Background: The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients. This leads to the postponement of elective surgeries including the treatment of abdominal aortic aneurysm (AAA). The probabilistic rupture risk index (PRRI) recently showed its advantage over the diameter criterion in AAA rupture risk assessment. Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion. The objective of this study was to test the clinical applicability of the PRRI method in a quasi-prospective patient cohort study. Methods: Nineteen patients (fourteen males, five females) with intact AAA who were postponed due to COVID-19 pandemic were included in this study. The PRRI was calculated at the baseline via finite element method models. If a case was diagnosed as high risk (PRRI > 3%), the patient was offered priority in AAA intervention. Cases were followed until 10 September 2021 and a number of false positive and false negative cases were recorded. Results: Each case was assessed within 3 days. Priority in intervention was offered to two patients with high PRRI. There were four false positive cases and no false negative cases classified by PRRI. In three cases, the follow-up was very short to reach any conclusion. Conclusions: Integrating PRRI into clinical workflow is possible. Longitudinal validation of PRRI did not fail and may significantly decrease the false positive rate in AAA treatment.